Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Endocrine 3Other 1

Conditions

Adrenal Gland Neoplasms 5Adrenal incidentaloma 3Pheochromocytoma 2Hypertension 2Cushing Syndrome 2Urinary Bladder Neoplasms 1Osteoporosis 1Obesity 1Hypokalemia 1Hypercholesterolemia 1Hyperaldosteronism 1Diabetes Mellitus 1Carcinoma, Renal Cell 1Adrenocortical Carcinoma 1Adrenocortical Adenoma 1

Interventions

Adrenalectomy 3Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Adrenal incidentaloma × Adrenalectomy × Endocrine × Clear all
NCT07200245 2025-10-01

HEMODYNAMICS

Central Hospital, Nancy, France

Not yet recruiting
522 enrolled
Endocrine

Adrenal incidentaloma, Pheochromocytoma

NCT04127552 2025-03-28

ITACA

University of Roma La Sapienza

Recruiting
68 enrolled
Endocrine

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome

NCT02001051 2018-06-14

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
4 enrolled 10 charts
EndocrineOther

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡